careers news & media events contact info site map  
  torrent   torrent pharmaceuticals limited  
 
   
 
Home  ::  Manufacturing  ::  Indrad Plant  ::  Introduction  
 

 

Overview ::

Torrent’manufacturing facility at Indrad, Gujarat, was set up in 1989. Today, the Indrad facility is at par with international standards. It complies with global regulatory norms including that of USFDA, WHO, cGMP, MHRA and others and has received Health, Safety (ISO-18001-2007),Environment System( ISO-14001-2004),Quality System Management (ISO 9001-2008)and Energy Management System (ISO 50001-2011) certifications; adequately reflecting Torrent’s commitment towards quality and safety. Attainment of such standards have also opened the key to gaining footholds in regulated, lucrative markets like the US and EU for Torrent Pharma.


Torrent firmly believes that quality cannot be talked into a product, but has to exist inherently. Its efforts towards realizing world-class manufacturing standards is reflected in its being awarded the 5 Star rating and Sword of Honor Award by British Safety Council

Infrastructure ::

  • Land - 194,000 sq. metres
  • Built-up Area – 46,000 sq. m for Formulations and 14,000 sq. m for API (additional 10000 sq m under expansion)
  • Finished Products – Oral Dosage Form, Injectables, Freeze Dried Sterile injection
  • API - Multi Product, Versatile Facility, Upgraded to International Standards

Manufacturing Capacities (per annum) ::

Formulations - Tablets 5000 million / annum
Formulations - Capsules 500 million / annum
Formulations - Vials 26 million /annum
Bulk Drugs/API 45,000 kg

Tie-up with Novo Nordisk ::

We have signed an agreement with Novo Nordisk India in August 2005 and part of our parenteral facility is dedicated for the formulation and packaging of Insulin, exclusively for Novo Nordisk. The facility will cater to the increased demand for Novo Nordisk Insulin products in India and will incorporate state of art technology in formulation, filling, inspection and packaging of Novo Nordisk insulin formulations.

This facility will have the requisite flexibility to expand and the production will be done with the same state of the art technology and quality standards as practiced across the world by Novo Nordisk.

We have been manufacturing Insulin for Novo Nordisk’s India requirement for more than 15 years now. Our parenteral site for insulin production is dedicated for Novo Nordisk products, and complies with their worldwide norms.


 
 
  Introduction »
» Overview
» Infrastructure
» Manufacturing Capacities
» Tie-up with Novo Nordisk

 

Copyright © 2003
careers faq news & media events contact info site map
^ TOP